PROteolysis TArgeting Chimera (PROTAC) Degrader Molecules Selectively Clear Proteins that Cause Neurological Diseases
Download the Full Event Guide for Full Session Details.
- Progress in orally bioavailable, CNS-penetrant PROTAC degraders
- Update on ARV-102 central target and pathway engagement
- Exploring new PROTAC approaches to neurological diseases